US$ 26.93
glp-1 receptor agonist nephrolithiasis Changes in 24-Hour Urine Chemistry in Patients with during Weight Loss with Glucagon-Like Peptide 1–Based Therapies Certain diabetes drugs linked to
Description
464 Notably, the carotid body expresses GLP-1R, which is implicated in the concurrent regulation of blood pressure and blood glucose

Likewise, the cardiovascular benefit of efpeglenatide was independent of GFR or the concomitant use of iSGLT-2, suggesting its additive and independent effect from the latter,85 as was also observed in the EXSCEL study.86 A recent meta-analysis of the 8 published cardiovascular safety clinical trials, and which included a total of 60

Running distance, food intake and body weight were measured daily before dosing of experimental compounds

doi: 10.1385/JMN:18:1-2:07

doi: 10.1016/0014-5793(86)81429-6 31 CalannaSChristensenMHolstJJLaferrreBGluudLLVilsbllTet al

(2018) 236:R2942
